1. Home
  2. IMRX vs WNEB Comparison

IMRX vs WNEB Comparison

Compare IMRX & WNEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRX
  • WNEB
  • Stock Information
  • Founded
  • IMRX 2008
  • WNEB 1853
  • Country
  • IMRX United States
  • WNEB United States
  • Employees
  • IMRX N/A
  • WNEB N/A
  • Industry
  • IMRX Biotechnology: Pharmaceutical Preparations
  • WNEB Savings Institutions
  • Sector
  • IMRX Health Care
  • WNEB Finance
  • Exchange
  • IMRX Nasdaq
  • WNEB Nasdaq
  • Market Cap
  • IMRX 232.9M
  • WNEB 195.7M
  • IPO Year
  • IMRX 2021
  • WNEB N/A
  • Fundamental
  • Price
  • IMRX $8.07
  • WNEB $12.10
  • Analyst Decision
  • IMRX Strong Buy
  • WNEB Buy
  • Analyst Count
  • IMRX 4
  • WNEB 2
  • Target Price
  • IMRX $13.75
  • WNEB $11.00
  • AVG Volume (30 Days)
  • IMRX 1.3M
  • WNEB 62.1K
  • Earning Date
  • IMRX 11-12-2025
  • WNEB 10-22-2025
  • Dividend Yield
  • IMRX N/A
  • WNEB 2.31%
  • EPS Growth
  • IMRX N/A
  • WNEB N/A
  • EPS
  • IMRX N/A
  • WNEB 0.59
  • Revenue
  • IMRX N/A
  • WNEB $76,036,000.00
  • Revenue This Year
  • IMRX N/A
  • WNEB N/A
  • Revenue Next Year
  • IMRX N/A
  • WNEB $7.36
  • P/E Ratio
  • IMRX N/A
  • WNEB $20.56
  • Revenue Growth
  • IMRX N/A
  • WNEB 2.15
  • 52 Week Low
  • IMRX $1.10
  • WNEB $7.63
  • 52 Week High
  • IMRX $9.37
  • WNEB $12.70
  • Technical
  • Relative Strength Index (RSI)
  • IMRX 69.91
  • WNEB 54.77
  • Support Level
  • IMRX $7.82
  • WNEB $11.90
  • Resistance Level
  • IMRX $8.85
  • WNEB $12.70
  • Average True Range (ATR)
  • IMRX 0.75
  • WNEB 0.22
  • MACD
  • IMRX 0.19
  • WNEB -0.10
  • Stochastic Oscillator
  • IMRX 69.91
  • WNEB 25.00

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

About WNEB Western New England Bancorp Inc.

Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the company's revenues, profits, and assets are derived by the Bank from banking products and services.

Share on Social Networks: